Angiotensin and Bradykinin: Targets for the Treatment of Vascular and Neuro-Glial Pathology in Diabetic Retinopathy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|27|3313-3330

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.27, 2004-10, pp. : 3313-3330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic issue: Possible Therapeutic Targets for the Treatment of Diabetic Retinopathy: Evidences from Experimental Models)

By  

Current Clinical Pharmacology, Vol. 8, Iss. 4, 2013-01 ,pp. : 265-265

Bentham Science Publishers

Access to resources Recommend Favorite

Fibrates and Statins in the Treatment of Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-03 ,pp. : 396-405

Bentham Science Publishers

Access to resources Recommend Favorite

Neuronal and Glial Cell Abnormality as Predictors of Progression of Diabetic Retinopathy

By  

Current Pharmaceutical Design, Vol. 13, Iss. 26, 2007-09 ,pp. : 2699-2712

Bentham Science Publishers

Access to resources Recommend Favorite

The Therapeutic Implications of Renin-Angiotensin System Blockade in Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-01 ,pp. : 392-395

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging therapeutic targets in diabetic vascular disease

By Schmidt A.M.   Stern D.M.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 3, 1999-09 ,pp. : 483-493

Informa Healthcare

Access to resources Recommend Favorite